Matches in Wikidata for { <http://www.wikidata.org/entity/Q88395820> ?p ?o ?g. }
- Q88395820 description "2018 nî lūn-bûn" @default.
- Q88395820 description "2018 ഏപ്രില് 18നു പ്രസിദ്ധീകരിച്ച ശാസ്ത്രീയ ലേഖനം" @default.
- Q88395820 description "2018年の論文" @default.
- Q88395820 description "2018年学术文章" @default.
- Q88395820 description "2018年学术文章" @default.
- Q88395820 description "2018年学术文章" @default.
- Q88395820 description "2018年学术文章" @default.
- Q88395820 description "2018年学术文章" @default.
- Q88395820 description "2018年学术文章" @default.
- Q88395820 description "2018年學術文章" @default.
- Q88395820 description "2018年學術文章" @default.
- Q88395820 description "2018年學術文章" @default.
- Q88395820 description "2018年學術文章" @default.
- Q88395820 description "2018年學術文章" @default.
- Q88395820 description "2018년 논문" @default.
- Q88395820 description "article científic" @default.
- Q88395820 description "article scientific" @default.
- Q88395820 description "article scientifique" @default.
- Q88395820 description "articol științific" @default.
- Q88395820 description "articolo scientifico" @default.
- Q88395820 description "artigo científico" @default.
- Q88395820 description "artigo científico" @default.
- Q88395820 description "artigo científico" @default.
- Q88395820 description "artikel ilmiah" @default.
- Q88395820 description "artikull shkencor" @default.
- Q88395820 description "artikulong pang-agham" @default.
- Q88395820 description "artykuł naukowy" @default.
- Q88395820 description "artículo científico publicado en 2018" @default.
- Q88395820 description "artículu científicu" @default.
- Q88395820 description "bilimsel makale" @default.
- Q88395820 description "bài báo khoa học" @default.
- Q88395820 description "naučni članak" @default.
- Q88395820 description "scienca artikolo" @default.
- Q88395820 description "scientific article published on 18 April 2018" @default.
- Q88395820 description "scientific article published on 18 April 2018" @default.
- Q88395820 description "scientific article published on 18 April 2018" @default.
- Q88395820 description "teaduslik artikkel" @default.
- Q88395820 description "tieteellinen artikkeli" @default.
- Q88395820 description "tudományos cikk" @default.
- Q88395820 description "vedecký článok" @default.
- Q88395820 description "vetenskaplig artikel" @default.
- Q88395820 description "videnskabelig artikel udgivet 18. april 2018" @default.
- Q88395820 description "vitenskapelig artikkel" @default.
- Q88395820 description "vitskapeleg artikkel" @default.
- Q88395820 description "vědecký článek" @default.
- Q88395820 description "wetenschappelijk artikel" @default.
- Q88395820 description "wissenschaftlicher Artikel" @default.
- Q88395820 description "επιστημονικό άρθρο" @default.
- Q88395820 description "мақолаи илмӣ" @default.
- Q88395820 description "наукова стаття, опублікована у квітні 2018" @default.
- Q88395820 description "научна статия" @default.
- Q88395820 description "научная статья" @default.
- Q88395820 description "научни чланак" @default.
- Q88395820 description "научни чланак" @default.
- Q88395820 description "מאמר מדעי" @default.
- Q88395820 description "مقالة علمية نشرت في 18 أبريل 2018" @default.
- Q88395820 description "১৮ এপ্রিল ২০১৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q88395820 description "บทความทางวิทยาศาสตร์" @default.
- Q88395820 description "სამეცნიერო სტატია" @default.
- Q88395820 name "A phase 1 study to assess the pharmacokinetics, safety, and tolerability of fremanezumab doses (225 mg, 675 mg and 900 mg) in Japanese and Caucasian healthy subjects" @default.
- Q88395820 name "A phase 1 study to assess the pharmacokinetics, safety, and tolerability of fremanezumab doses (225 mg, 675 mg and 900 mg) in Japanese and Caucasian healthy subjects" @default.
- Q88395820 type Item @default.
- Q88395820 label "A phase 1 study to assess the pharmacokinetics, safety, and tolerability of fremanezumab doses (225 mg, 675 mg and 900 mg) in Japanese and Caucasian healthy subjects" @default.
- Q88395820 label "A phase 1 study to assess the pharmacokinetics, safety, and tolerability of fremanezumab doses (225 mg, 675 mg and 900 mg) in Japanese and Caucasian healthy subjects" @default.
- Q88395820 prefLabel "A phase 1 study to assess the pharmacokinetics, safety, and tolerability of fremanezumab doses (225 mg, 675 mg and 900 mg) in Japanese and Caucasian healthy subjects" @default.
- Q88395820 prefLabel "A phase 1 study to assess the pharmacokinetics, safety, and tolerability of fremanezumab doses (225 mg, 675 mg and 900 mg) in Japanese and Caucasian healthy subjects" @default.
- Q88395820 P1433 Q88395820-0570E2CF-47D1-47CA-A42A-73F9FFDBA21D @default.
- Q88395820 P1476 Q88395820-EA95652E-8F53-46FF-9766-B9CCAE7111F8 @default.
- Q88395820 P2093 Q88395820-05DBC829-88D7-4B1A-A291-74CCE0D8EA04 @default.
- Q88395820 P2093 Q88395820-18AD7C1B-56B9-4B1A-9466-5EF98C90B268 @default.
- Q88395820 P2093 Q88395820-21470C0B-36DB-414D-9CA9-BC9F38FC0B56 @default.
- Q88395820 P2093 Q88395820-33649638-5EE1-4760-9845-15E66D8684A0 @default.
- Q88395820 P2093 Q88395820-79D39019-046E-498D-BBD0-FC08588270B9 @default.
- Q88395820 P2093 Q88395820-8DC9E806-3A00-408C-B9CB-E338A8715C0F @default.
- Q88395820 P2093 Q88395820-CF22C528-A8C7-44E1-A8DE-D321ADE437D1 @default.
- Q88395820 P2093 Q88395820-DD3C3BD9-34E0-475B-BF0C-D04BAE60E3F9 @default.
- Q88395820 P2093 Q88395820-E0420439-A7C7-4DF4-AACA-06EEE9B239A8 @default.
- Q88395820 P2093 Q88395820-FD21755A-8021-461A-85BF-6B3CE6F50C4B @default.
- Q88395820 P304 Q88395820-9AFF9457-1D12-4522-AF93-D9598AF79876 @default.
- Q88395820 P31 Q88395820-0CA0458A-E812-4B2A-B6C6-0219D4FB405C @default.
- Q88395820 P356 Q88395820-8458F961-11C6-4053-A769-B824769F5AFE @default.
- Q88395820 P433 Q88395820-9CAE3099-2F5D-49AD-87D8-A7BA4645298F @default.
- Q88395820 P478 Q88395820-B60D9036-9990-450B-B121-ACA4AB7D0220 @default.
- Q88395820 P577 Q88395820-BF8674FF-F4E3-471A-A911-9C43D28658DA @default.
- Q88395820 P698 Q88395820-05A0A9ED-C70A-4B12-962E-C17BA3980EE0 @default.
- Q88395820 P921 Q88395820-0E65C83D-F6B5-41A8-8687-9D422E2D3E9C @default.
- Q88395820 P921 Q88395820-AB4BE968-22B2-46E9-A238-F7311D09D675 @default.
- Q88395820 P356 0333102418771376 @default.
- Q88395820 P698 29667896 @default.
- Q88395820 P1433 Q5063251 @default.
- Q88395820 P1476 "A phase 1 study to assess the pharmacokinetics, safety, and tolerability of fremanezumab doses (225 mg, 675 mg and 900 mg) in Japanese and Caucasian healthy subjects" @default.
- Q88395820 P2093 "Ernesto Aycardi" @default.
- Q88395820 P2093 "Esther Yoon" @default.
- Q88395820 P2093 "Michele Rasamoelisolo" @default.
- Q88395820 P2093 "Mohit D Gandhi" @default.
- Q88395820 P2093 "Nicola Faulhaber" @default.
- Q88395820 P2093 "Ofer Spiegelstein" @default.
- Q88395820 P2093 "Orit Cohen-Barak" @default.
- Q88395820 P2093 "Paul P Yeung" @default.
- Q88395820 P2093 "Pippa S Loupe" @default.